• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Endocrinology

FDA-approved weight loss medications associated with weight loss at one year

byJeffrey CohenandMichael Milligan
June 15, 2016
in Endocrinology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. In this meta-analysis, orlistat, lorcaserin, naltrexone-bupropion, phentermine-topiramate, and liraglutide all had a statistically significant odds ratio of achieving 5% weight loss when compared to placebo.

2. Phentermine-topiramate had greater odds of achieving both 5% and 10% weight loss than other medications and had no increased occurrence of adverse events.

Evidence Rating Level: 2 (Good)

Study Rundown: Obesity is an important public health problem in the United States and internationally. One strategy to combat obesity is oral medications to assist individuals with weight loss. This meta-analysis included randomized controlled trials (RCTs) of the five FDA approved oral medications for obesity (orlistat, lorcaserin, naltrexone-bupropion, phentermine-topiramate, and liraglutide) to compare their efficacy for weight loss and side effect profiles. Outcomes were assessed at one year and the primary weight loss outcome was 5% reduction in weight (a level of weight loss deemed clinically significant by the FDA). Twenty-eight trials were included in the study, and all five agents were associated with a greater odds of achieving at least 5% weight loss when compared to placebo. Additionally, phentermine-topiramate had greater odds of achieving both 5% and 10% weight loss than other medications and had no increased occurrence of adverse events.

The strengths of this study include the use of only RCTs and the standardized data extracted from each study. However, it is limited by its use of network meta-analyses to compare agents against one another, and the primary endpoint at only 1 year. Ultimately, this study suggests that oral medications can assist individuals in achieving weight loss. However, more RCTs comparing medications directly over longer periods are needed to better understand the effect of oral medications on obesity.

Click to read the study, published today in JAMA

Relevant Reading: Long-term drug treatment for obesity: a systematic and clinical review.

RELATED REPORTS

Time restricted eating not more beneficial than daily calorie restriction

Wellness Check: Nutrition

Weight loss and lifestyle changes may improve symptoms of obstructive sleep apnea in overweight men

In-Depth [meta-analysis]: This meta-analysis compared the efficacy of the five FDA approved oral medications for obesity (orlistat, lorcaserin, naltrexone-bupropion, phentermine-topiramate, and liraglutide) on their effectiveness in achieving 5% weight loss and the occurrence adverse effects. For odds of achieving weight loss compared to placebo, orlistat had an OR of 2.70 (95%CI 2.34-3.09), lorcaserin an OR of 3.10 (95%CI 2.35-4.05), naltrexone-burpopion an OR of 3.95 (95%CI 3.03-5.11), phentermine-topiramate an OR of 9.22 (95%CI 6.63-12.85), and liraglutide an OR of 5.54 (95%CI 4.16-7.78). Phentermine-topiramate had greater odds of achieving both 5% and 10% weight loss at 52 weeks than other medications and was not associated with an increase in adverse events.

 

Image: CC/Wiki

©2016 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: obesityweight loss
Previous Post

Hirschsprung disease associated with maternal obesity and preterm birth

Next Post

Neutralizing antibodies protect against SHIV infection in young macaques [PreClinical]

RelatedReports

Sleep duration inversely related to childhood type 2 diabetes risk makers
Cardiology

Time restricted eating not more beneficial than daily calorie restriction

May 13, 2022
Provision of medically-tailored meals linked with lower admissions and medical spending
Wellness

Wellness Check: Nutrition

May 5, 2022
Admission may not be needed following sleep apnea surgery
Chronic Disease

Weight loss and lifestyle changes may improve symptoms of obstructive sleep apnea in overweight men

April 28, 2022
Many new pediatric asthma cases attributable to obesity
Chronic Disease

Obesity may be associated with better response to immune checkpoint blockade therapy

April 1, 2022
Next Post
Government-funded initiatives provide important supports to low-income HIV patients

Neutralizing antibodies protect against SHIV infection in young macaques [PreClinical]

Lariat device for left atrial appendage exclusion associated with adverse events

2 Minute Medicine Rewind June 13, 2016

Nanoparticle delivery of aurora kinase inhibitor may improve tumor treatment [PreClinical]

Low-cost test rapidly detects Zika virus [PreClinical]

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

Get 2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • #VisualAbstract: Severe actinic keratosis and need for additional treatment are markers for an increased risk of cutaneous squamous cell carcinoma
  • Virtual yoga and meditation intervention may be associated with increased health-related quality of life
  • Wellness Check: Mental Health
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.